We are live on
!
Find out more
HAM
Highstreet Asset Management Portfolio holdings
AUM
$2.22B
1-Year Est. Return
20.88%
This Fund
S&P 500
This Quarter
Est. Return
+5.04%
1 Year Est. Return
+20.88%
3 Year Est. Return
+22.52%
5 Year Est. Return
+37.85%
10 Year Est. Return
–
AUM
$468M
AUM Growth
+$164M
(+54%)
Cap. Flow
+$159M
Cap. Flow
% of AUM
33.9%
Top 10 Holdings %
Top 10 Hldgs %
21.4%
Holding
188
New
47
Increased
80
Reduced
48
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$6.35M |
| 2 |
Abbott
ABT
|
+$6.2M |
| 3 |
Johnson & Johnson
JNJ
|
+$5.77M |
| 4 |
Eli Lilly
LLY
|
+$5.48M |
| 5 |
Pfizer
PFE
|
+$5.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$4.23M |
| 2 |
CGI
GIB
|
+$3.37M |
| 3 |
Bank of Montreal
BMO
|
+$2.61M |
| 4 |
TransAlta
TAC
|
+$1.87M |
| 5 |
PepsiCo
PEP
|
+$1.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.04% |
| 2 | Financials | 17.09% |
| 3 | Technology | 12.63% |
| 4 | Energy | 10.64% |
| 5 | Industrials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Canadian Natural Resources
CNQ
$93.8B
| $5.59M | 1.19% |
528,913
+44,205
| +9% | +$494K |
|
27
Elevance Health
ELV
$85.5B
| $5.52M | 1.18% |
39,587
+32,709
| +476% | +$4.51M |
|
28
Teva Pharmaceuticals
TEVA
$41.2B
| $5.33M | 1.14% |
81,120
+77,972
| +2,477% | +$4.82M |
|
29
Chevron
CVX
$366B
| $5.19M | 1.11% |
57,738
+259
| +0.5% | +$23.4K |
|
30
GSK
GSK
$106B
| $5.17M | 1.1% |
+102,400
| New | +$5.22M |
|
31
UnitedHealth
UNH
$370B
| $5.16M | 1.1% |
+43,900
| New | +$5.13M |
|
32
Manulife Financial
MFC
$73.5B
| $5.11M | 1.09% |
341,032
-40,314
| -11% | -$650K |
|
33
Becton Dickinson
BDX
$48.2B
| $5.07M | 1.08% |
+33,723
| New | +$4.85M |
|
34
Quest Diagnostics
DGX
$26.3B
| $5.06M | 1.08% |
+71,100
| New | +$4.78M |
|
35
Gilead Sciences
GILD
$165B
| $4.97M | 1.06% |
+49,100
| New | +$5.11M |
|
36
Brookfield
BN
$108B
| $4.93M | 1.05% |
445,014
-78,539
| -15% | -$921K |
|
37
AbbVie
ABBV
$435B
| $4.93M | 1.05% |
+83,200
| New | +$4.79M |
|
|
STJ
38
DELISTED
St Jude Medical
STJ
| $4.87M | 1.04% |
+78,900
| New | +$4.98M |
|
39
Sanofi
SNY
$104B
| $4.72M | 1.01% |
+110,600
| New | +$5.09M |
|
40
ExxonMobil
XOM
$634B
| $4.68M | 1% |
60,089
+14,589
| +32% | +$1.17M |
|
41
Novartis
NVS
$297B
| $4.68M | 1% |
+60,710
| New | +$4.82M |
|
42
TC Energy
TRP
$65.9B
| $4.67M | 1% |
142,782
+31,933
| +29% | +$1.06M |
|
43
Verizon
VZ
$196B
| $4.59M | 0.98% |
99,320
-9,354
| -9% | -$425K |
|
44
3M
MMM
$94.3B
| $4.54M | 0.97% |
36,052
-12,771
| -26% | -$1.64M |
|
45
Alphabet (Google) Class A
GOOGL
$4.33T
| $3.91M | 0.84% |
+100,540
| New | +$3.72M |
|
46
Enbridge
ENB
$112B
| $3.88M | 0.83% |
116,547
+762
| +0.7% | +$28.6K |
|
47
Boeing
BA
$185B
| $3.77M | 0.81% |
26,082
-781
| -3% | -$112K |
|
48
Accenture
ACN
$108B
| $3.76M | 0.8% |
36,012
+29,200
| +429% | +$3.08M |
|
49
Deere & Co
DE
$168B
| $3.66M | 0.78% |
48,016
+24,189
| +102% | +$1.87M |
|
50
Meta Platforms (Facebook)
META
$1.51T
| $3.63M | 0.78% |
34,734
+17,001
| +96% | +$1.75M |
|
Similar funds
CM
TRAM
MP
CONA
CBU
BC
SC
KGACF
Highstreet Asset Management's Q4 2015 Portfolio in Review
As of Q4 2015, Highstreet Asset Management held 188 positions worth $468M, up 54% from $304M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Highstreet Asset Management deployed $159M of net new capital in Q4 2015, opening 47 new positions and adding to 80 existing holdings. Its largest new stake was Medtronic: 84,339 shares worth $6.49M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 9.3% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Bausch Health, an estimated $4.23M trimmed.
- Highstreet Asset Management's largest Q4 2015 buy was Medtronic: 84,339 shares worth $6.49M.
- Highstreet Asset Management added most to Abbott in Q4 2015, an estimated $6.2M increase.
- Highstreet Asset Management's biggest Q4 2015 reduction was Bausch Health, cutting an estimated $4.23M.
- Highstreet Asset Management fully exited CGI in Q4 2015, selling an estimated $3.37M.
- Highstreet Asset Management's ten largest holdings make up 21% of its $468M portfolio in Q4 2015.
- Highstreet Asset Management opened 47 new positions and closed 10 in Q4 2015.
- Highstreet Asset Management's portfolio value rose 54% quarter-over-quarter to $468M.
Based on Highstreet Asset Management's 13F filing for Q4 2015, filed 29 Jan 2016.